Yuanqi Xie

Title: Innovations in Cancer Treatment by Inventor Yuanqi Xie

Introduction

Yuanqi Xie is a notable inventor based in Cleveland, OH (US), recognized for his contributions to the field of cancer treatment. He holds 2 patents that focus on predicting immunotherapy responses in non-small cell lung cancer (NSCLC). His innovative work aims to enhance treatment plans for patients suffering from this challenging disease.

Latest Patents

Yuanqi Xie's latest patents include groundbreaking technologies that utilize imaging techniques to assess tumor responses to immunotherapy. The first patent, titled "Predicting immunotherapy response in non-small cell lung cancer with serial radiomics," describes a system that includes an image acquisition circuit for pre-treatment and post-treatment images. This system annotates and registers the tumor images, extracts relevant radiomic features, and generates a probability of response to immunotherapy. The classification circuit ultimately helps in determining whether the tumor is a responder or non-responder, facilitating tailored treatment plans.

The second patent, "Predicting immunotherapy response in non-small cell lung cancer with serial quantitative vessel tortuosity," employs a similar approach but focuses on quantitative vessel tortuosity (QVT) features. This invention also includes an image acquisition circuit, a segmentation and registration circuit, and a classification circuit that assesses the likelihood of a positive response to immunotherapy based on the differences in QVT features.

Career Highlights

Yuanqi Xie is affiliated with Case Western Reserve University, where he continues to advance research in cancer treatment technologies. His work is pivotal in bridging the gap between imaging technology and personalized medicine, particularly in oncology.

Collaborations

Yuanqi collaborates with esteemed colleagues such as Anant Madabhushi and Vamsidhar Velcheti, who contribute to the research and development of innovative solutions in cancer treatment.

Conclusion

Yuanqi Xie's contributions to the field of cancer treatment through his patents demonstrate his commitment to improving patient outcomes. His innovative approaches in predicting immunotherapy responses are paving the way for more effective and personalized treatment strategies.